Point of View Articles
Loading...
Why poor target validation is costing pharmaceutical businesses millions
Point of View
It has been well documented that only 1 out of 10 compounds that enter clinical trials makes it to market¹. That is an astonishing 90% failure rate. It is hard to imagine hiring a lawyer or doctor or any professional who fails so often. Yet in our industry, it remains the norm.
Loading...
Advancing Clinical Care using AI: A case of Hemorrhagic Disease of Newborn
General
Point of View
Working as a pediatrician caring for ill, hospitalized children is a tremendously rewarding occupation, but getting it right can be hard. Evidence-based medicine has now been a standard all physicians are directed to follow for at least the last few decades, but how is a clinician to meet that standard when working in a field of medicine that has limited existing evidence?
